EXT1 and Its Methylation Involved in the Progression of Uterine Corpus Endometrial Carcinoma Pathogenesis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The gene EXT1 is identified as a potential biomarker for uterine corpus endometrial carcinoma (UCEC). Its increased expression and methylation correlate with poor prognosis, and targeting EXT1 may offer new therapeutic strategies for UCEC.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Uterine corpus endometrial carcinoma (UCEC) presents high recurrence and metastasis rates, necessitating novel diagnostic and therapeutic biomarkers.
- Identifying predictive markers is crucial for improving patient outcomes in UCEC.
- Current research focuses on understanding the molecular mechanisms driving UCEC progression.
Purpose Of The Study
- To screen for and identify novel predictive markers for UCEC using bioinformatics and experimental validation.
- To investigate the role of the gene EXT1 in the development and progression of UCEC.
- To explore the impact of EXT1 methylation and expression on UCEC cell behaviors.
Main Methods
- Utilized R software and The Cancer Genome Atlas (TCGA) database for candidate marker screening.
- Performed Western blot and RT-qPCR to analyze EXT1 expression in UCEC cell lines.
- Conducted MTT, flow cytometry, Transwell, and wound healing assays to assess UCEC cell viability, apoptosis, invasion, and migration.
- Employed overlap-extension PCR to construct vectors for targeting EXT1 methylation segments.
Main Results
- Identified 11 candidate genes, with EXT1 emerging as a significant potential target.
- Observed increased expression and methylation levels of EXT1 in UCEC tissues and cell lines.
- Found a correlation between elevated EXT1 levels and poorer patient prognosis.
- Demonstrated that knockdown of EXT1 significantly inhibited malignant behaviors (viability, migration, invasion) in UCEC cells.
- Showed that deletion of a specific CpG island segment in EXT1 upregulated its expression and promoted malignant behaviors.
- Detected the presence of m7G RNA methylation in UCEC cells.
Conclusions
- The methylation of EXT1 influences gene expression, impacting malignant biological behaviors in UCEC cells.
- EXT1 plays a critical role in the pathological progression of UCEC.
- Targeting EXT1 and its methylation status presents a promising avenue for UCEC diagnosis and therapy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
In most mammals, females have two X chromosomes (XX) while males have an X and a Y chromosome (XY). The X chromosome contains significantly more genes than the Y chromosome. Therefore, to prevent an excess of X chromosome-linked gene expression in females, one of the two X chromosomes is randomly silenced during early development....
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...